Agostini, Lidiane PignatonStur, ElaineGarcia, Fernanda M.Ventorim, Diego P.Reis, Raquel S. dosDettogni, Raquel S.Santos, Eldamária V. W. dosPeterle, Gabriela T.Maia, Lucas L.Mendes, Suzanny O.Carvalho, Marcos B. deTajara, Eloiza H.Paula, Flavia deSantos, Marcelo dosSilva, Adriana M. A. daLouro, Iúri Drumond2021-02-032021-02-032017-12AGOSTINI, Lidiane Pignaton et al. ATM, BCL2, and TGFβ Gene Polymorphisms as Radiotherapy Outcome Biomarkers in Head and Neck Squamous Cell Carcinoma Patients. Genetic Testing And Molecular Biomarkers, [s.l.], v. 21, n. 12, p. 727-735, dez. 2017. Mary Ann Liebert Inc. Disponível em: https://www.liebertpub.com/doi/10.1089/gtmb.2017.0180. Acesso em: 30 jun. 2020. http://dx.doi.org/10.1089/gtmb.2017.0180.1945-0257 (online)1945-0265 (print)https://repositorio.ufrn.br/handle/123456789/31363Attribution-NonCommercial 3.0 Brazilhttp://creativecommons.org/licenses/by-nc/3.0/br/Head and neck squamous cell carcinomaOral cavity/oropharynxLarynxRadiosensitivityPolymorphismsATM, BCL2, and TGFb gene polymorphisms as radiotherapy outcome biomarkers in head and neck squamous cell carcinoma patientsarticle10.1089/gtmb.2017.0180